before and after semaglutide 1 month JOURNEY RECAP // How I lost 30 lbs in 3 months, milestones, challenges + sustainability Well You Life – Wellness

According to the available timelines, the phase 3 clinical trial is expected to conclude in early 2026 with potential FDA approval in 2027

The growing body of evidence suggests that the effects of GLP-1 RAs extend beyond a single organ and can positively influence health across various organ systems and specific health conditions, indicating their potential use for non-obese but otherwise metabolically healthy individuals to enhance their overall well-being

So the US Department of Agriculture, those of us of a certain age, you can tell by my hair Its silver by the way that Ive been doing this for a while

Study findings A total of 113 adults with T1D were screened, among which 28 candidates (61% female and HbA1c of 7.4%) were recruited

When patients start GLP-1 receptor agonist therapy, one of their first questions is whether their prescribed dose is normal or appropriate for their body